Ameritas Investment Partners’s Ventyx Biosciences VTYX Stock Holding History

Ameritas Investment Partners’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,650	Closed	-$5.35K	–	3356
2025 Q1	$5.35K	Hold	4,650	–	–	﹤0.01%	2957
2024 Q4	$10.2K	Hold	4,650	–	–	﹤0.01%	2897
2024 Q3	$10.1K	Hold	4,650	–	–	﹤0.01%	2914
2024 Q2	$10.7K	Hold	4,650	–	–	﹤0.01%	2894
2024 Q1	$25.6K	Hold	4,650	–	–	﹤0.01%	2465
2023 Q4	$11.5K	Hold	4,650	–	–	﹤0.01%	2803
2023 Q3	$161K	Buy	4,650 +785	+20%	+$27.1K	0.01%	1322
2023 Q2	$127K	Buy	3,865 +1,870	+94%	+$64.5K	﹤0.01%	1432
2023 Q1	$66.8K	Hold	1,995	–	–	﹤0.01%	1798
2022 Q4	$69.6K	Buy	1,995 +314	+19%	+$9.3K	﹤0.01%	1834
2022 Q3	$58K	Hold	1,681	–	–	﹤0.01%	1871
2022 Q2	$20K	Buy	1,681 +874	+108%	+$13.1K	﹤0.01%	2549
2022 Q1	$11K	Hold	807	–	–	﹤0.01%	2774
2021 Q4	$16K	Buy	+807	New	+$15.3K	﹤0.01%	2745

Other funds holding VTYX

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Ameritas Investment Partners's VTYX Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Ventyx Biosciences (VTYX) in Q2 2025, closing a stake of 4,650 shares — an estimated $5.35K sold.

Ameritas Investment Partners first reported a position in VTYX in Q4 2021 and held it in 14 quarters. The position peaked at $161K in Q3 2023. 114 funds tracked by Wall St. Rank hold VTYX as of Q2 2025.

Ameritas Investment Partners reported no remaining Ventyx Biosciences position as of Q2 2025 after selling out during the quarter.
Ameritas Investment Partners sold 4,650 Ventyx Biosciences shares in Q2 2025, an estimated $5.35K.
Ameritas Investment Partners first reported a position in Ventyx Biosciences in Q4 2021 and held it in 14 quarters.
Ameritas Investment Partners's Ventyx Biosciences position peaked at $161K in Q3 2023.
114 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.